Foley is pleased to be a Gold sponsor of the Sino-American Biomedical and Pharmaceutical Association (SABPA) 5th Annual Pacific Forum. The conference brings together entrepreneurs, scientists, investors, executives, and policy makers to promote life sciences and biotechnology alliances across the Pacific Rim, including the U.S. West coast, greater China region, and Singapore.
Foley Partner Stephen Bent will participate on a panel discussion on November 7th at 2:30 p.m. on “What is Your China Play – Doing Business in a Shifting Regulatory, Investment, and Economic Environment.”
For more information about the SABPA 5th Annual Pacific Forum, please visit the SABPA Web site.
People
Related Insights
May 1, 2026
Manufacturing Industry Advisor
A New DOL Joint Employment Rule? What Franchisors Need to Know
On April 22, 2026, the U.S. Department of Labor's Wage and Hour Division published a proposed rule to establish a single, nationwide…
May 27, 2026
Events
ABA’s Qui Tam & Civil False Claims and Healthcare Fraud Institute 2026
Foley partner Lisa Noller, Chair of the Firm’s Litigation Department, will be speaking at the American Bar Association’s Qui Tam & Civil False Claims and Healthcare Fraud Institute in Washington, D.C. from May 27-28.
April 30, 2026
Foley Viewpoints
Sizing Up The 3-Way Battle For 'Iceman' IP Rights
Trademark rights in the U.S. arise from use in commerce, not from registration alone. The Lanham Act's first-to-use framework means that a party who can demonstrate earlier, continuous commercial use of a mark holds superior rights over a later filer. This principle is the backbone of Gervin's case against Williams.